Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 325,838,176
  • Shares Outstanding, K 2,682,900
  • Annual Sales, $ 76,450 M
  • Annual Income, $ 1,300 M
  • 36-Month Beta 0.73
  • Price/Sales 4.31
  • Price/Cash Flow 12.83
  • Price/Book 5.20

Price Performance

See More
Period Period Low Period High Performance
1-Month
118.62 +3.56%
on 05/29/18
124.85 -1.61%
on 06/08/18
-0.07 (-0.06%)
since 05/22/18
3-Month
118.62 +3.56%
on 05/29/18
132.88 -7.56%
on 04/16/18
-4.54 (-3.56%)
since 03/22/18
52-Week
118.62 +3.56%
on 05/29/18
148.32 -17.18%
on 01/17/18
-13.21 (-9.71%)
since 06/22/17

Most Recent Stories

More News
Real-World Study of More than 700,000 People with Type 2 Diabetes (T2D) Shows No Increased Risk of Below-Knee Lower Extremity Amputations with INVOKANA® (canagliflozin) Compared to Other Diabetes Medications

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced late-breaking results of a new real-world analysis of more than 700,000 U.S. T2D patients, which found no increased risk of below-knee...

JNJ : 122.84 (+1.14%)
Real-World Evidence Shows Oral INVOKANA® (canagliflozin) Results in Greater Weight Loss and Treatment Adherence Than Injectable GLP-1 Receptor Agonists in Type 2 Diabetes Patients

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new findings from two real-world studies comparing sodium glucose co-transporter-2 inhibitor (SGLT2i) INVOKANA® (canagliflozin)...

IREHF : 2.8800 (unch)
JNJ : 122.84 (+1.14%)
Exxon Mobil and CarMax jump; Red Hat and Tesla tumble

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Friday:

ADSK : 136.51 (-0.89%)
XOM : 81.38 (+2.12%)
JNJ : 122.84 (+1.14%)
RHT : 142.14 (-14.23%)
Look for Shares of Johnson&Johnson to Potentially Pullback after Yesterday's 1.42% Rise

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $121.65 to a high of $123.22. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of...

JNJ : 122.84 (+1.14%)
Johnson & Johnson Appoints Senior Leaders to Executive Committee

Johnson & Johnson (NYSE: JNJ) today announced the appointment of a number of senior leaders to the Company's Executive Committee.

JNJ : 122.84 (+1.14%)
Johnson & Johnson Announces Retirement of Group Worldwide Chairman, Sandra E. Peterson

Johnson & Johnson (NYSE: JNJ) announced today that Sandra (Sandi) E. Peterson, Group Worldwide Chairman for Johnson & Johnson, has announced her plans to retire from J&J effective October 1, 2018.

JNJ : 122.84 (+1.14%)
The Dow then and now: original, current members of index

NEW YORK (AP) — S&P Dow Jones Indices announced Tuesday that General Electric would be replaced in the Dow Jones industrial average by Walgreens Boots Alliance.

CVX : 125.10 (+2.05%)
JNJ : 122.84 (+1.14%)
PG : 77.43 (+1.30%)
PFE : 36.51 (+0.58%)
BA : 338.91 (+0.37%)
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 17, to review second-quarter results. Alex Gorsky, Chairman and Chief Executive Officer...

JNJ : 122.84 (+1.14%)
IPS HEART, Resident of Johnson & Johnson Innovation, Uses Human Stem Cells for the First Time to Actually Reverse Heart Attack Damage

IPS HEART, resident of Johnson & Johnson Innovation, JLABS is pioneering the use of IPS cellular therapy for the replacement of heart tissue after heart attack, heart failure and duchenne...

JNJ : 122.84 (+1.14%)
Reinvigorated Healthcare Industry Being Boosted by Quantitative Advancements and Device Breakthroughs

MarketNewsUpdates.com News Commentary

FBIO : 3.24 (unch)
ZENO : 0.3851 (+16.70%)
JNJ : 122.84 (+1.14%)
BEAT : 46.05 (-0.54%)
IRTC : 78.70 (-0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade JNJ with:

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 124.35
1st Resistance Point 123.60
Last Price 122.84
1st Support Level 121.87
2nd Support Level 120.89

See More

52-Week High 148.32
Fibonacci 61.8% 136.97
Fibonacci 50% 133.47
Fibonacci 38.2% 129.97
Last Price 122.84
52-Week Low 118.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar